This summary was created by AI, based on 1 opinions in the last 12 months.
Treatment.com AI, represented by the symbol TRUE-CN, is emerging as a frontrunner in employing artificial intelligence to enhance efficiency in the medical field. Its unique medical language model is tailored specifically to a finite universe of medical data, enabling it to assist a range of healthcare professionals—from doctors and receptionists to 911 dispatchers and nursing centers—in diagnosing issues effectively. The company has garnered attention for being debt-free and has recently signed a strategic deal with the University of Edinburgh, which is expected to bolster its credibility and expansion. As Treatment.com AI continues to secure additional deals, the potential for cash flow positivity is on the horizon, marking it as a promising investment in the healthcare tech sector.
Treatment.com AI is a Canadian stock, trading under the symbol TRUE-CN on the Canadian Securities Exchange (). It is usually referred to as or TRUE-CN
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
Treatment.com AI was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Treatment.com AI.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
On 2025-04-02, Treatment.com AI (TRUE-CN) stock closed at a price of $0.47.
Using AI to make things more efficient. Medical language model, using a finite universe of only medical data. Helps doctors to diagnose issues. Can be used by medical office receptionists, doctors, 911 dispatchers, nursing centres. Debt free. Deal signed with University of Edinburgh. A few more deals should make them cashflow positive.